CMS: State Medicaid programs must now cover medication-assisted treatment
State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.
Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a reminder notice.
Related News Articles
Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
The Centers for Medicare & Medicaid Services Oct. 16 approved section 1115 demonstration amendments which will allow Medicaid and Children's Health…
Headline
The Centers for Medicare & Medicaid Services Sept. 26 released guidance on state compliance with the Early and Periodic Screening, Diagnostic and Treatment…
Headline
The Centers for Medicare & Medicaid Services Aug. 15 released a state funding notice for the Cell and Gene Therapy Access Model. The CGT Access Model will…